Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Cardiology | Family Medicine | Internal Medicine | Journal

Back to Journal Articles

LDL Cholesterol Subfraction Testing of Limited Value

Last Updated: April 07, 2009.

 

Authors conclude that routine use of low-density lipoprotein subfraction testing to estimate cardiovascular risk is premature

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Measures of low-density lipoprotein (LDL) subfractions -- such as small dense LDL particles, medium LDL particles or large LDL particles -- do not add incremental benefit to traditional risk factor assessment for cardiovascular disease, according to a report published in the April 7 issue of the Annals of Internal Medicine.

TUESDAY, April 7 (HealthDay News) -- Measures of low-density lipoprotein (LDL) subfractions -- such as small dense LDL particles, medium LDL particles or large LDL particles -- do not add incremental benefit to traditional risk factor assessment for cardiovascular disease, according to a report published in the April 7 issue of the Annals of Internal Medicine.

Stanley Ip, M.D., of Tufts Medical Center in Boston, and colleagues conducted a systematic review of 24 studies that reported an association between LDL subfractions and incidence or severity of cardiovascular disease, including 10 studies that used nuclear magnetic resonance.

The researchers found that all 24 studies showed that an increased risk for cardiovascular disease was consistently associated with a higher LDL particle number, which was independent of other lipid measurements. They also found that an increased risk of cardiovascular disease was generally not associated with LDL subfractions after adjustment for cholesterol concentrations.

"Strong observational data suggested a positive association between plasma concentrations of homocysteine and cardiovascular outcomes, but randomized trials of treatments that successfully decreased homocysteine concentrations did not result in statistically significant benefit on cardiovascular end points or total mortality," the authors conclude. "Thus, even if LDL subfraction testing proves to be associated with cardiovascular outcomes, the tests will be of clinical value only if treatments based on the results of the LDL subfraction testing prove to be beneficial."

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Healthy Seniors Likely to Forgo Colorectal Screening Next: Repetitive Training Offers Benefits After Cortex Damage

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.